Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. - Chan,A.W.; Chew,D.P.; Bhatt,D.L.; Moliterno,D.J.; Topol,E.J.; Ellis,S.G. (Am J Cardiol, 2002)